Cohen Neil Harris bought CMMB
March 7, 2022 · Form 4 insider transaction
Cohen Neil Harris bought 1,705 shares of Chemomab Therapeutics Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1639 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,705
Price
$0.00
Total value
N/A
InsiderCohen Neil Harris
Role—
SecurityStock option (right to buy American Depositary Shares)
Transaction codeA: Grant or award
Transaction dateMarch 7, 2022
Filing dateSeptember 1, 2026
Shares owned after4,848
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options reported in this row were granted to the Reporting Person by the Issuer on March 7, 2022, and are fully vested and exercisable as of the date of this report.